[1] |
SUN Xiaorui, ZHAO Ning, ZHANG Luyong, JIANG Zhenzhou, WANG Xinzhi.
Research Progress in Drug-Related Liver Injury in the Treatment of Autoimmune Diseases
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(5): 523-527.
|
[2] |
CAO Weiping, ZHANG Shichao, NI Xia, XIE Bing, WANG Xinzhi, XING Mengtao.
Research Progress in Liver Injury Caused by Drugs Commonly Used during Pregnancy
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(5): 528-531.
|
[3] |
CHEN Qingyu, JIANG Zhenzhou, ZHANG Luyong.
Research Progress in Adaptive Response of Hepatocytes in Intrinsic Drug-Induced Liver Injury
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(5): 532-538.
|
[4] |
WANG Li, TANG Jinling, LI Cuihong, TAN Feilong, YOU Lina, ZHAO Fangyun.
One Case of Acute Severe Liver Injury Caused by High-Dose Dexamethasone Sodium Phosphate Injection
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(5): 589-591.
|
[5] |
CHEN Huan, LIANG Jun, ZHAO Wei, XIA Qingrong.
Clinical Features and Risk Factors of Liver Injury Induced by Atypical Antipsychotic Drugs
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(4): 410-414.
|
[6] |
LONG Minjuan, ZHAO Xu, GUO Longxin, CAI Yuhan, LIN Li, ZHU Shengkai, LIU Wenlong, SONG Haibo, XIAO Xiaohe.
Big Data Analysis of Liver Adverse Reactions Monitoring of Chinese and Western Medicines Based on Age Correction and Risk Warning for Dermatologic Drugs
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(3): 271-275.
|
[7] |
TANG Qianhui, ZHANG Haoran, ZHANG Luyong, JIANG Zhenzhou.
Research Progress in Triptolide-Induced Live Injury
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(2): 121-127.
|
[8] |
TANG Qianhui, ZHU Ying, ZHANG Haoran, ZHANG Luyong, JIANG Zhenzhou.
Roles of Hepatocellular NF-κB Signaling Pathway in Triptolide-Induced Indirect Liver Injury
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(2): 128-138.
|
[9] |
HU Yaping, ZHANG Aiwu.
One Case of Acute Drug-Induced Liver Injury Caused by Tingli Jiangxuezhi Capsules
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(2): 224-226.
|
[10] |
HU Xiaowen, ZHANG Caiyu, WANG Fengfeng, PU Hengting, LIU Yang, CHEN Hua.
Improving DILI prediction methods based on defined daily dose
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(7): 776-780.
|
[11] |
SHAO Bo, XU Lili, ZHU Lan, LIU Shuo, WAN Hao, HUANG Guangrui.
Risks of liver injury caused by Shiduqing preparations
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(6): 666-670.
|
[12] |
LIN Yanxin, LIU Yanhui, DONG Jing, YAO Jiachen, LI Wenyan.
Pharmaceutical care of acute liver injury in a patient with colon cancer induced by irinotecan
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(6): 693-696.
|
[13] |
CAO Guiping, DENG Linlin, ZHU Ganhong, LU Ying, MA Shuang, CHEN Linlin, Liu Lili.
One case of severe liver injury caused by Tianma Shouwu tablets
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 216-218.
|
[14] |
WANG Xin, SHI Leilei, ZHANG Yuhan, XIE Yundong, LIU Jiping.
The role of MRPs transporters in drug-induced liver injury
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 229-234.
|
[15] |
LI Yanyi, WEN Hairuo, YANG Yanrong, MA Shuangcheng, WANG Qi.
Identification of Hepatotoxic Components of Polygoni Multiflori Radix Based on Material Basis Combined with Heparg Cell Experiments
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(12): 1377-1381.
|